Tradestie Institutional Equity Comparison Engine

PTNQ vs ACB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACB Overall Edge

ACB Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aurora Cannabis Inc. Common Shares (ACB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PTNQ trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ACB at 109.9x Forward P/E and -13.8% operating margin (-8.8% YoY). In options structure, PTNQ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACB sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ACB
PTNQ N/M vs ACB 109.9x Fwd P/E
Growth & Margin Winner ACB
Op Margin N/A vs -13.8% ยท YoY N/A vs -8.8%
Momentum & Technical Winner ACB
1Y +1.6% vs +5.0% ยท 52W Pos 40% vs 54%
Options & Structure Winner ACB
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (6th %ile IV)
PTNQ NASDAQ
Pacer Trendpilot 100 ETF
Institutional Equity
$79.80
-2.59% 1D
Market Cap N/A
1M Return -6.81%
1Y Return +1.64%
Forward P/E N/M
Unified AI Score
54.5 / 100 HOLD
Tech 56.0 Fund 61.0 Flow 50.0 Mom 60.0
ACB NASDAQ
Aurora Cannabis Inc. Common Shares
Medicinal Chemicals & Botanical Products
$4.61
-6.68% 1D
Market Cap $324.8M
1M Return +15.54%
1Y Return +5.01%
Forward P/E 109.9x
Unified AI Score
40.1 / 100 SELL
Tech 15.0 Fund 40.0 Flow 61.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PTNQ +1.64% ACB +5.01% Spread: +3.37 pp (ACB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PTNQ TTM Op. Margin: N/A ACB TTM Op. Margin: -13.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PTNQ vs ACB. Trailing 12-month operating profitability (PTNQ N/A vs ACB -13.8%) and valuation multiples (PTNQ N/M vs ACB 109.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PTNQ (2) vs ACB (8)
Institutional Metric PTNQ ACB Criterion Row Winner
Market Capitalization Scale N/A $324.8M Larger Scale ACB
Trailing P/E Ratio Valuation N/M 109.9x Lower Multiple ACB
Forward P/E Ratio Valuation N/M 109.9x Lower Multiple ACB
Revenue Growth (YoY) Growth N/A -8.8% Higher Growth ACB
Operating Margin (TTM) Profitability N/A -13.8% Higher Margin ACB
Net Profit Margin Profitability N/A -38.2% Higher Margin ACB
Return on Equity (ROE) Capital Efficiency N/A -9.4% Higher ROE ACB
52-Week Range Position Momentum 40% ($72โ€“$92) 54% ($3โ€“$6) Stronger Trend ACB
Beta / 30D Volatility Risk Regime 1.40ฮฒ ยท 35% Vol 1.07ฮฒ ยท 87% Vol Lower Realized Risk PTNQ
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 40.1 / 100 (SELL) Higher Composite PTNQ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PTNQ vs ACB Buy Guide
PTNQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PTNQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACB CONSOLIDATION
29d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PTNQ nor ACB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.